High incidence of malignancies in patients with dermatomyositis and polymyositis: An 11-year analysis

被引:101
作者
Maoz, CR
Langevitz, P [1 ]
Livneh, A
Blumstein, Z
Sadeh, M
Bank, I
Gur, H
Ehrenfeld, M
机构
[1] Chaim Sheba Med Ctr, Dept Med F, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
dermatomyositis; polymyositis; malignancy; neoplasm;
D O I
10.1016/S0049-0172(98)80052-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Dermatomyositis and polymyositis (DM/PM) are associated with neoplasms. The aim of the present study is to compare our experience in Israel with other published data. Methods: Thirty-five adult patients with DM/PM, admitted to Sheba Medical Center during the 11-year interval between 1984 and 1994, were studied for the prevalence and features of malignant diseases. Patients with DM/PM alone and with DM/PM and malignancy were identified by using the hospital computer system. The manifestations of DM/PM and features of the malignant diseases were abstracted from the patients' charts. The presence or absence of malignancy and the type of cancer were verified in the National Cancer Registry. Results: There were 15 men and 20 women. The mean age at the onset of the disease was 53 +/- 18 years. A total of 15 had PM and 20 DM. Malignancies occurred in four patients with PM (27%) and in nine with DM (45%) a frequency 12.6 times higher than in the general population. In six patients, the malignancy and the DM/PM were diagnosed simultaneously; in four before and in three after the appearance of the DM/PM. Hematologic, gastrointestinal, breast, ovarian, and lung tumors, malignant melanoma, and metastatic carcinoma of unknown primary were found among our patients. Eight DM/PM patients with malignancy died during the study period of infection, pulmonary embolism, and tumor spread. Conclusions: Our study found that DM/PM is associated with high rates of malignancy and mortality. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:319 / 324
页数:6
相关论文
共 60 条
[1]  
AMORETTI A R, 1961, An Fac Med Univ Repub Montev Urug, V46, P77
[2]   DERMATOMYOSITIS AND MALIGNANT NEOPLASMS IN ADULTS - A SURVEY OF 20 YEARS EXPERIENCE [J].
ARUNDELL, FD ;
WILKINSON, RD ;
HASERICK, JR .
ARCHIVES OF DERMATOLOGY, 1960, 82 (05) :772-775
[3]  
ASMAN A, 1991, J RHEUMATOL, V18, P1272
[4]  
BARNES BE, 1976, ANN INTERN MED, V84, P68, DOI 10.7326/0003-4819-84-1-68
[5]  
BARON M, 1985, J RHEUMATOL, V12, P283
[6]   PROGNOSTIC FACTORS AND PREDICTIVE SIGNS OF MALIGNANCY IN ADULT DERMATOMYOSITIS - A STUDY OF 32 CASES [J].
BASSETSEGUIN, N ;
ROUJEAU, JC ;
GHERARDI, R ;
GUILLAUME, JC ;
REVUZ, J ;
TOURAINE, R .
ARCHIVES OF DERMATOLOGY, 1990, 126 (05) :633-637
[7]   PROGNOSTIC FACTORS IN POLYMYOSITIS - DERMATOMYOSITIS - A COMPUTER-ASSISTED ANALYSIS OF 92 CASES [J].
BENBASSAT, J ;
GEFEL, D ;
LARHOLT, K ;
SUKENIK, S ;
MORGENSTERN, V ;
ZLOTNICK, A .
ARTHRITIS AND RHEUMATISM, 1985, 28 (03) :249-255
[8]  
BERNARD P, 1993, J INVEST DERMATOL, V100, pS128, DOI 10.1111/1523-1747.ep12356956
[9]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[10]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347